Drugs Xagena
Zonisamide ( Zonegran ) is a sulphonamide derivative that inhibits carbonic anhydrase; it resembles Topiramate ( Topamax ). The main clinical trial, a double-blind study lasting 36 weeks, compared ...
The FDA ( Food and Drug Administration ) issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors in patients who take drugs called ...
The FDA ( Food and Drug Administration ) has completed its analysis of reports of suicidality ( suicidal behavior or ideation ) from placebo-controlled clinical trials of drugs used to treat epileps ...
The European Commission ( EC ) has approved extension application regarding the use of antiepileptic agent Zonegran ( Zonisamide ) in the treatment of paediatric patients. The approval extends the use ...
